MMSI logo

Merit Medical Systems, Inc. (MMSI) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

69.70$'dan işlem gören Merit Medical Systems, Inc. (MMSI), 5B değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 49/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 9 Şub 2026
49/100 AI Puanı Hedef $97.00 (+39.2%) PD 5B Hacim 314K

Merit Medical Systems, Inc. (MMSI) Sağlık ve Boru Hattı Genel Bakışı

CEOMartha Goldberg Aronson
Çalışanlar7400
MerkezSouth Jordan, UT, US
Halka Arz Yılı1990
SektörHealthcare

Merit Medical Systems, Inc. (MMSI) offers specialized medical devices for interventional procedures, driving growth through innovation in cardiology, radiology, and endoscopy. With a strong focus on single-use products and a global distribution network, MMSI presents a compelling investment in the expanding medical technology sector.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 9 Şub 2026

Yatırım Tezi

Merit Medical Systems presents a notable research candidate due to its focus on high-growth interventional medical procedures. The company's strategic focus on single-use devices in cardiology, radiology, and endoscopy aligns with increasing demand for minimally invasive treatments. With a current P/E ratio of 41.27 and a solid gross margin of 48.5%, MMSI demonstrates financial stability and profitability. Key growth catalysts include expanding its product portfolio through innovation and strategic acquisitions, as well as increasing its market share in both the Cardiovascular and Endoscopy segments. The company's global distribution network and strong relationships with hospitals and physicians provide a competitive advantage. Investors may want to evaluate MMSI for its potential to deliver long-term growth and value in the expanding medical device market.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $4.89B reflects investor confidence in Merit Medical's growth potential.
  • P/E ratio of 41.27 indicates a premium valuation, reflecting expectations of future earnings growth.
  • Gross Margin of 48.5% demonstrates strong pricing power and efficient cost management.
  • Operating in the Cardiovascular and Endoscopy segments, aligning with high-growth areas in medical technology.
  • Beta of 0.61 suggests lower volatility compared to the overall market, indicating a relatively stable investment.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product portfolio across multiple medical specialties.
  • Global distribution network.
  • Focus on single-use medical devices.
  • Strong relationships with hospitals and physicians.

Zayıflıklar

  • High P/E ratio indicates premium valuation.
  • Dependence on third-party distributors.
  • Potential for product recalls or liability claims.
  • Exposure to currency exchange rate fluctuations.

Katalizörler

  • Upcoming: New product launches in the Cardiovascular and Endoscopy segments.
  • Ongoing: Strategic acquisitions to expand product portfolio and market reach.
  • Ongoing: Increasing demand for minimally invasive procedures.
  • Ongoing: Expansion into emerging markets with high growth potential.

Riskler

  • Potential: Product recalls or liability claims related to medical devices.
  • Potential: Regulatory changes and healthcare reforms impacting pricing and reimbursement.
  • Potential: Economic downturns affecting hospital budgets and capital expenditures.
  • Ongoing: Competition from established and emerging medical device companies.
  • Ongoing: Currency exchange rate fluctuations impacting international sales.

Büyüme Fırsatları

  • Growth opportunity 1: Expanding its product portfolio through strategic acquisitions presents a significant growth opportunity for Merit Medical. By acquiring companies with complementary technologies and products, Merit Medical can broaden its offerings and enter new markets. The market for interventional medical devices is estimated at $40 billion, providing ample opportunity for growth through acquisitions. Timeline: Ongoing.
  • Growth opportunity 2: Increasing market share in the Endoscopy segment is a key growth driver for Merit Medical. The global endoscopy market is projected to reach $15 billion by 2028, driven by the increasing prevalence of gastrointestinal diseases and the demand for minimally invasive diagnostic and therapeutic procedures. Merit Medical can capitalize on this trend by expanding its product offerings and strengthening its relationships with gastroenterologists and pulmonologists. Timeline: Ongoing.
  • Growth opportunity 3: Expanding its global presence, particularly in emerging markets, offers substantial growth potential. The demand for medical devices is increasing rapidly in countries like China and India, driven by rising healthcare expenditure and improving access to healthcare services. Merit Medical can leverage its existing distribution network and establish new partnerships to penetrate these markets. Timeline: Ongoing.
  • Growth opportunity 4: Developing and commercializing innovative products for interventional oncology represents a significant growth opportunity. The market for interventional oncology devices is projected to reach $5 billion by 2027, driven by the increasing incidence of cancer and the demand for targeted therapies. Merit Medical can leverage its expertise in interventional procedures to develop innovative solutions for cancer diagnosis and treatment. Timeline: Ongoing.
  • Growth opportunity 5: Enhancing its custom procedural solutions business, which includes critical care products, disinfection protection systems, and manifold kits, offers a stable and recurring revenue stream. The market for custom procedure trays is estimated at $10 billion, driven by the increasing demand for standardized and efficient medical procedures. Merit Medical can strengthen its position in this market by expanding its product offerings and providing customized solutions to hospitals and physicians. Timeline: Ongoing.

Fırsatlar

  • Expanding product portfolio through strategic acquisitions.
  • Increasing market share in emerging markets.
  • Developing innovative products for interventional oncology.
  • Strengthening its custom procedural solutions business.

Tehditler

  • Increasing competition from established and emerging medical device companies.
  • Regulatory changes and healthcare reforms.
  • Economic downturns affecting hospital budgets.
  • Technological obsolescence.

Rekabet Avantajları

  • Specialized product portfolio focused on interventional procedures.
  • Strong relationships with hospitals and physicians.
  • Global distribution network.
  • Expertise in single-use medical device manufacturing.

MMSI Hakkında

Merit Medical Systems, Inc., founded in 1987 and headquartered in South Jordan, Utah, is a global manufacturer and marketer of single-use medical devices. The company focuses on interventional, diagnostic, and therapeutic procedures, primarily serving the cardiology, radiology, oncology, critical care, and endoscopy markets. Merit Medical operates through two segments: Cardiovascular and Endoscopy. The Cardiovascular segment provides products for peripheral and cardiac interventions, including access, angiography, electrophysiology, fluid management, and hemostasis devices. The Endoscopy segment offers products for pulmonary and gastroenterology procedures, including stents, dilation balloons, and accessories. Merit Medical's products are sold to hospitals, physicians, and original equipment manufacturers through a direct sales force, distributors, and custom procedure tray manufacturers. The company's focus on innovation and strategic acquisitions has allowed it to expand its product portfolio and geographic reach, establishing a strong position in the medical device industry. With a commitment to improving patient outcomes and providing cost-effective solutions, Merit Medical continues to drive growth and create value for its stakeholders. The company's diverse product offerings and global presence contribute to its resilience and long-term growth potential.

Ne Yaparlar

  • Designs, develops, and manufactures single-use medical products.
  • Offers products for interventional, diagnostic, and therapeutic procedures.
  • Focuses primarily on cardiology, radiology, oncology, critical care, and endoscopy.
  • Provides peripheral intervention products for treating diseases in vessels and organs.
  • Offers cardiac intervention products for various heart conditions.
  • Supplies pulmonary products, including stents and dilation balloons.
  • Provides gastroenterology products and accessories.
  • Offers custom procedural solutions, including critical care products and disinfection systems.

İş Modeli

  • Develops and manufactures single-use medical devices.
  • Sells products directly to hospitals and physicians through a direct sales force.
  • Utilizes distributors and OEM partners to expand market reach.
  • Offers custom procedure trays to meet specific customer needs.

Sektör Bağlamı

Merit Medical Systems operates within the medical device industry, which is characterized by continuous innovation and increasing demand for minimally invasive procedures. The global medical device market is projected to reach $600 billion by 2025, driven by an aging population and advancements in medical technology. The competitive landscape includes established players and emerging companies focused on specialized segments. Merit Medical's focus on single-use devices and its presence in both the Cardiovascular and Endoscopy markets position it favorably to capitalize on these trends. The company's ability to develop and commercialize innovative products will be crucial for maintaining its competitive edge and capturing market share.

Kilit Müşteriler

  • Hospitals and alternate site-based physicians.
  • Technicians and nurses.
  • Original equipment manufacturer partners.
  • Custom procedure tray manufacturers.
AI Güveni: 72% Güncellendi: 9 Şub 2026

Finansallar

Grafik & Bilgi

Merit Medical Systems, Inc. (MMSI) hisse senedi fiyatı: $69.70 (+1.59, +2.33%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

MMSI için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $97.00

MoonshotScore

49/100

Bu puan ne anlama geliyor?

MoonshotScore, MMSI'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

En Son Merit Medical Systems, Inc. Analizi

MMSI Healthcare Hisse Senedi SSS

MMSI için değerlendirilmesi gereken temel faktörler nelerdir?

Merit Medical Systems, Inc. (MMSI) şu anda yapay zeka skoru 49/100, düşük puanı gösteriyor. Hisse 32.2x F/K oranıyla işlem görüyor, S&P 500 ortalamasına (~20-25x) yakın. Analist hedefi $97.00 ($69.70'dan +39%). Temel güçlü yan: Diverse product portfolio across multiple medical specialties.. İzlenmesi gereken birincil risk: Potential: Product recalls or liability claims related to medical devices.. Bu bir finansal tavsiye değildir.

MMSI MoonshotScore'u nedir?

MMSI şu anda MoonshotScore'da 49/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

MMSI verileri ne sıklıkla güncellenir?

MMSI fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler MMSI hakkında ne diyor?

Analistler, MMSI için $97.00 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($69.70) yukarı yönlü %39 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

MMSI'a yatırım yapmanın riskleri nelerdir?

MMSI için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Product recalls or liability claims related to medical devices.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

MMSI'ın P/E oranı nedir?

Merit Medical Systems, Inc. (MMSI)'nın son P/E oranı 32.2, ki bu da orta bir aralıkta. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

MMSI aşırı değerli mi, yoksa düşük değerli mi?

Merit Medical Systems, Inc. (MMSI)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 32.2. Analist hedefi $97.00 (mevcut fiyattan +39%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

MMSI'ın temettü verimi nedir?

Merit Medical Systems, Inc. (MMSI) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Fiyat itibarıyla Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Stock data pending update. Financial metrics based on available data as of 2026-02-09. Future performance is subject to market conditions and company-specific factors.
Veri Kaynakları

Popüler Hisseler